Labcorp completed the acquisition of select assets of Deerfield-backed Invitae for $239m.

Labcorp, an innovative and comprehensive laboratory services, completed the acquisition of select assets of Deerfield-backed Invitae, a medical genetics company, for $239m. "The agreement with Labcorp marks a significant step in our financial restructuring and supports our efforts to continue to deliver innovative and industry leading products and services for healthcare," Ken Knight, Invitae President and CEO.